Home/Filings/4/0001749705-20-000005
4//SEC Filing

WOJCZYNSKI DAVID E 4

Accession 0001749705-20-000005

CIK 0001552033other

Filed

Feb 24, 7:00 PM ET

Accepted

Feb 25, 6:22 PM ET

Size

10.3 KB

Accession

0001749705-20-000005

Insider Transaction Report

Form 4
Period: 2020-02-21
WOJCZYNSKI DAVID E
EVP, Healthcare
Transactions
  • Exercise/Conversion

    Stock Options (right to buy)

    2020-02-21$8.57/sh1,800$15,4260 total
    Exercise: $8.57Exp: 2024-04-01Common Stock (1,800 underlying)
  • Award

    Common Stock

    2020-02-21+3,59335,357 total
  • Exercise/Conversion

    Common Stock

    2020-02-21$8.57/sh+1,800$15,42637,157 total
  • Sale

    Common Stock

    2020-02-21$100.00/sh9,053$905,30028,104 total
Footnotes (3)
  • [F1]Represents a grant of restricted stock units that vest ratably over three years, i.e., 33% on the first anniversary of the date of grant, 33% on the second anniversary of the date of grant, and 34% on the third anniversary of the date of grant.
  • [F2]This transaction was effected pursuant to a Rule 10b5-1 trading plan.
  • [F3]Represents an initial grant of 35,990 stock options, 40% of which vest upon the attainment of time-based vesting criteria and 60% of which vest upon the attainment of both time-based and performance-based vesting criteria. The performance-based vesting criteria was satisfied on February 22, 2017, and all options now follow the time-based vesting criteria as follows: 20% on the first anniversary of the date of grant and 5% on the last day of each subsequent full calendar quarter.

Issuer

TransUnion

CIK 0001552033

Entity typeother

Related Parties

1
  • filerCIK 0001749705

Filing Metadata

Form type
4
Filed
Feb 24, 7:00 PM ET
Accepted
Feb 25, 6:22 PM ET
Size
10.3 KB